Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

Measurement of fibroblast proliferative activity in bronchoalveolar lavage fluid in the analysis of obliterative bronchiolitis among lung transplant recipients.

Jonosono M, Fang KC, Keith FM, Turck CW, Blanc PD, Hall TS, Fukano AK, Rifkin CJ, Gold WM, Webb WR, Edinburgh KJ, Finkbeiner WE, Golden JA.

J Heart Lung Transplant. 1999 Oct;18(10):972-85.

PMID:
10561108
2.

Airway versus transbronchial biopsy and BAL in lung transplant recipients: different but complementary.

Ward C, Snell GI, Orsida B, Zheng L, Williams TJ, Walters EH.

Eur Respir J. 1997 Dec;10(12):2876-80.

3.

Bronchoalveolar lavage in lung transplantation. State of the art.

Tiroke AH, Bewig B, Haverich A.

Clin Transplant. 1999 Apr;13(2):131-57. Review.

PMID:
10202611
5.

A prospective molecular surveillance study evaluating the clinical impact of community-acquired respiratory viruses in lung transplant recipients.

Kumar D, Husain S, Chen MH, Moussa G, Himsworth D, Manuel O, Studer S, Pakstis D, McCurry K, Doucette K, Pilewski J, Janeczko R, Humar A.

Transplantation. 2010 Apr 27;89(8):1028-33. doi: 10.1097/TP.0b013e3181d05a71.

PMID:
20075787
6.

Value of high-resolution computed tomography in routine evaluation of lung transplantation recipients during development of bronchiolitis obliterans syndrome.

Ikonen T, Kivisaari L, Harjula AL, Lehtola A, Heikkilä L, Kinnula VL, Kyösola K, Savola J, Sipponen J, Verkkala K, Mattila SP.

J Heart Lung Transplant. 1996 Jun;15(6):587-95.

PMID:
8803756
7.

Eosinophilic granulocytes and interleukin-6 level in bronchoalveolar lavage fluid are associated with the development of obliterative bronchiolitis after lung transplantation.

Scholma J, Slebos DJ, Boezen HM, van den Berg JW, van der Bij W, de Boer WJ, Koëter GH, Timens W, Kauffman HF, Postma DS.

Am J Respir Crit Care Med. 2000 Dec;162(6):2221-5.

PMID:
11112142
8.

Obliterative bronchiolitis after lung transplantation: a fibroproliferative disorder associated with platelet-derived growth factor.

Hertz MI, Henke CA, Nakhleh RE, Harmon KR, Marinelli WA, Fox JM, Kubo SH, Shumway SJ, Bolman RM 3rd, Bitterman PB.

Proc Natl Acad Sci U S A. 1992 Nov 1;89(21):10385-9.

9.

Comparison of serum KL-6 versus bronchoalveolar lavage neutrophilia for the diagnosis of bronchiolitis obliterans in lung transplantation.

Ohshimo S, Bonella F, Sommerwerck U, Teschler H, Kamler M, Jakob HG, Kohno N, Guzman J, Costabel U.

J Heart Lung Transplant. 2011 Dec;30(12):1374-80. doi: 10.1016/j.healun.2011.07.010. Epub 2011 Aug 25.

PMID:
21871820
10.

Diagnostic yield and therapeutic impact of flexible bronchoscopy in lung transplant recipients.

Chan CC, Abi-Saleh WJ, Arroliga AC, Stillwell PC, Kirby TJ, Gordon SM, Petras RE, Mehta AC.

J Heart Lung Transplant. 1996 Feb;15(2):196-205.

PMID:
8672524
11.

Surveillance bronchoscopy in lung transplant recipients: risk versus benefit.

McWilliams TJ, Williams TJ, Whitford HM, Snell GI.

J Heart Lung Transplant. 2008 Nov;27(11):1203-9. doi: 10.1016/j.healun.2008.08.004. Epub 2008 Oct 1.

PMID:
18971092
12.

Clinical utility of bronchoalveolar lavage cell phenotype analyses in the postoperative monitoring of lung transplant recipients.

Reynaud-Gaubert M, Thomas P, Gregoire R, Badier M, Cau P, Sampol J, Giudicelli R, Fuentes P.

Eur J Cardiothorac Surg. 2002 Jan;21(1):60-6.

PMID:
11788258
13.

Experimental large-animal model of obliterative bronchiolitis after lung transplantation.

al-Dossari GA, Kshettry VR, Jessurun J, Bolman RM 3rd.

Ann Thorac Surg. 1994 Jul;58(1):34-9; discussion 39-40.

PMID:
8037556
14.

Elevated peptides in lung lavage fluid associated with bronchiolitis obliterans syndrome.

Stone MD, Harvey SB, Nelsestuen GL, Reilly C, Hertz MI, Wendt CH.

PLoS One. 2014 Jan 2;9(1):e84471. doi: 10.1371/journal.pone.0084471. eCollection 2014.

15.

Actuarial survival of heart-lung and bilateral sequential lung transplant recipients with obliterative bronchiolitis.

Valentine VG, Robbins RC, Berry GJ, Patel HR, Reichenspurner H, Reitz BA, Theodore J.

J Heart Lung Transplant. 1996 Apr;15(4):371-83.

PMID:
8732596
16.

Airway vascular changes after lung transplant: potential contribution to the pathophysiology of bronchiolitis obliterans syndrome.

Langenbach SY, Zheng L, McWilliams T, Levvey B, Orsida B, Bailey M, Williams TJ, Snell GI.

J Heart Lung Transplant. 2005 Oct;24(10):1550-6.

PMID:
16210129
17.

Bronchoalveolar lavage neutrophilia is associated with obliterative bronchiolitis after lung transplantation: role of IL-8.

DiGiovine B, Lynch JP 3rd, Martinez FJ, Flint A, Whyte RI, Iannettoni MD, Arenberg DA, Burdick MD, Glass MC, Wilke CA, Morris SB, Kunkel SL, Strieter RM.

J Immunol. 1996 Nov 1;157(9):4194-202.

PMID:
8892657
18.
19.

Prognostic value of bronchoalveolar lavage neutrophilia in stable lung transplant recipients.

Neurohr C, Huppmann P, Samweber B, Leuschner S, Zimmermann G, Leuchte H, Baumgartner R, Hatz R, Frey L, Ueberfuhr P, Bittmann I, Behr J; Munich Lung Transplant Group.

J Heart Lung Transplant. 2009 May;28(5):468-74. doi: 10.1016/j.healun.2009.01.014. Epub 2009 Mar 14.

PMID:
19416775
20.

Proteomic bronchiolitis obliterans syndrome risk monitoring in lung transplant recipients.

Wolf T, Oumeraci T, Gottlieb J, Pich A, Brors B, Eils R, Haverich A, Schlegelberger B, Welte T, Zapatka M, von Neuhoff N.

Transplantation. 2011 Aug 27;92(4):477-85. doi: 10.1097/TP.0b013e318224c109.

PMID:
21716170

Supplemental Content

Support Center